willdate
Cardiologists share COVID-19 insights
Cardiologists from across Europe have shared their experience of having treated COVID-19 patients, in a series of videos produced by the European Society of...
Virtual ACC: Mavacamten “promising” in treatment of non-obstructive hypertrophic cardiomyopathy
Results from the phase 2 MAVERICK-HCM clinical trial, presented at the American College of Cardiology/World Congress of Cardiology’s virtual scientific sessions (ACC.20/WCC Virtual) suggest that...
Virtual ACC: Medtronic shares positive results of Onyx ONE Clear Study
Medtronic today announced positive results of the Onyx ONE Clear Study that evaluated the Resolute Onyx drug-eluting stent (DES) in high bleeding risk (HBR)...
Virtual ACC: High success rate for TAVI in bicuspid aortic stenosis...
Transcatheter aortic valve implantation (TAVI) procedures had a high rate of success and low risk of death or disabling stroke at 30 days in...
AHA commits US$2.5 million for fast-tracked COVID-19 heart and brain research
The American Heart Association (AHA) has committed US$2.5 million to research efforts to better understand the novel coronavirus, COVID-19, and its interaction with the...
Append Medical share clinical proof-of-concept results for internal sealing of LAA
Append Medical, developer of the Appligator, a novel left atrial appendage (LAA) closure device to minimise stroke risk in atrial fibrillation (AF) patients, and...
VitalConnect adds arrhythmia detection to its remote monitoring software
VitalConnect has announced the introduction of arrhythmia detection to its remote monitoring portfolio. In partnership with CorVitals, VitalConnect now offers physicians the ability to...
AI-guided cardiac imaging system given FDA authorisation
The US Food and Drug Administration (FDA) has authorised marketing of software to assist in the acquisition of cardiac ultrasound, or echocardiography, images. The...
First patient enrolled in PREDICT-LAA clinical trial
FEops has announced that the first patient has been enrolled in the physician-initiated PREDICT-LAA trial.
The trial is led by Righshospitalet (Copenhagen, Denmark) and aims...
ACC makes senior staff appointments
The American College of Cardiology (ACC) has announced several promotions and structural changes within its senior staff. The College said that the staff changes...
FDA grants Breakthrough designation for ECG-based algorithm
The US Food and Drug Administration has granted Breakthrough Device designation to the digital health and artificial intelligence (AI) company Eko for an echocardiogram...
European trial data ‘reinforce’ safety profile and efficacy of Lixiana
Daiichi Sankyo Europe has announced outcomes from an observational study in mainly caucasian atrial fibrillation (AF) patients being treated with the anti-coagulation drug edoxaban...
AHA 2019: Endotronix shares data from in-human trial of Cordella pulmonary...
Endotronix has presented first-in-human data of the Cordella pulmonary artery pressure sensor System at the 2019 American Heart Association (AHA) Scientific Sessions (16–18 November,...
Left atrial appendage closure associated with a decreased stroke risk in...
Left atrial appendage closure (LAAC) via implanted device was associated with a decreased risk of admission for stroke, compared with the expected risk without...
